News JP Morgan and Amazon could inform US health policy Big data and telehealth could improve US system, says Dimon
News Brexit talks collapse again, but sector deal makes pharma up... A dramatic veto from Northern Ireland’s Democratic Unionist Party (DUP) saw Theresa May’s hopes of clinching a ‘divorce settlement’ with the European Union collapse yesterday.
News Pharma urges Scotland to invest in R&D, manufacturing Pharma industry driving growth where job prospects are weaker
News Warning over 'handful' of scientists researching new antibio... UK government 'losing focus' on issue since Brexit vote.
News Strategy for post-Brexit life science sector unveiled Plan aims to solve long-standing issue of access to medicines
News Disappointment as government delays pharma-friendly policies Proposals fall short of ambitions of Accelerated Access Review.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.